LIGAND PHARMACEUTICALS INCORPORATED (LGND) /

The cash flow of LIGAND PHARMACEUTICALS INCORPORATED over the past 10 years

Chart LIGAND PHARMACEUTICALS INCORPORATED: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, LIGAND PHARMACEUTICALS INCORPORATED's operating cash flow was $49.36M and its capital expenditures $452K, leaving free cash flow of $48.91M. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$31.89M in fiscal 2019 to $193.17M in fiscal 2018. Capital expenditures were highest in fiscal 2022, at $17.92M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$49.36M$452K$48.91M
2024ended Dec 31, 2024$97.05M$1.82M$95.23M
2023ended Dec 31, 2023$49.58M$3.52M$46.06M
2022ended Dec 31, 2022$137.85M$17.92M$119.93M
2021ended Dec 31, 2021$78.8M$8.76M$70.04M
2020ended Dec 31, 2020$54.59M$4.46M$50.13M
2019ended Dec 31, 2019-$29.34M$2.55M-$31.89M
2018ended Dec 31, 2018$194.06M$887K$193.17M
2017ended Dec 31, 2017$88.57M$2.16M$86.41M
2016ended Dec 31, 2016$60.73M$1.85M$58.88M

Fiscal years as LIGAND PHARMACEUTICALS INCORPORATED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on LIGAND PHARMACEUTICALS INCORPORATED

Companies of a similar size

Not investment advice. This page shows what LIGAND PHARMACEUTICALS INCORPORATED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.